Skip to content

Society welcomes £22bn investment in UK science

The Chancellor of the Exchequer presented his Budget to Parliament on 11 March, announcing a landmark £22bn investment in UK science by 2024-25. The Society welcomes this investment as a step change in funding and a significant, long-term commitment to developing the UK as a ‘science superpower’.
 
Along with partners in the sector, the Society has been calling for overall UK investment in science to reach at least 2.4% of GDP by 2027, increasing from the current 1.7%. Overall investment combines public funding with that of the private and third sectors. To reach this target, the Campaign for Science and Engineering (CaSE) has modelled that absolute investment needs to reach £65bn by this date.
 
Investing wisely in the UK’s world-leading science - and in the research capability of the NHS - can help boost international competitiveness, attracting the funding and collaborations that will ultimately benefit patients and society.
 
 Further details of spending allocation will be detailed through the upcoming spending review. The Campaign for Science and Engineering have published an explainer of what is currently known about how this investment will be directed.

Latest news & activity

Press releases

Following on from its recent publication of the 2025 Annual Review, the British Pharmacological Society has launched its new BPS Strategy 2026 - 2030:…

Annual Review

We’re pleased to share our 2025 Annual Review, which is now live!

The Annual Review captures a year of progress and purpose across the British…

Event announcement

 

The wait is over... Pharmacology 2026 is now open for registration! See below to find out how to get the best value for money, how to share your…